Meeting Agenda for the Advisory Committee on Breast Cancer in Young Women
View Printable Version pdf icon[PDF-171KB]
Meeting Objectives
To advise the Secretary of the Department of Health and Human Services (HHS) and the Director of the Centers for Disease Control and Prevention (CDC) regarding the formative research, development, implementation, and evaluation of evidence-based activities designed to prevent breast cancer in young women (particularly among those at heightened risk).
Upcoming Meeting: Friday, November 20, 2020
8:00 – 8:15 a.m.
Opening: Welcome, Roll Call, and Introductions
Jeremy McCallister
Designated Federal Officer, DCPC, CDC
Elana Silber, MBA
Sharsheret
ACBCYW Committee Chair
8:15 – 8:30 a.m.
CDC Updates
Temeika L. Fairley, PhD
Senior Health Scientist, DCPC, CDC
8:30 – 9:15 a.m.
Barriers to Care Presentation
Lisa Schlager
Facing Our Risk of Cancer Empowered (FORCE)
Vice President, Public Policy
9:15 – 10:45 a.m.
Work Group Reports and Discussion
Genetics & Genomics Workgroup
Shubhada Dhage, MD, FACS
NYU Perlmutter Cancer Center
Joyce Tannenbaum Turner, MS, CGC
Children’s National Medical Center
Mental/Behavioral Health Workgroup
Mylin Torres, MD
Winship Cancer Institute
Michele Maria Cerullo, JD
DaVita Medical Group
Provider Workgroup
Lindsay Avner
Bright Pink
Kenneth Lin, MD, MPH
Georgetown University Medical Center
Sexual Health Workgroup
Lisa Astalos Chism, DNP, APRN, NCMP, FAANP
Oakland Macomb Obstetrics & Gynecology Associates
Ellyn Davidson
Brogan & Partners
10:45 – 11:00 a.m.
Break
11:00 a.m. – 12:15 p.m.
ACBCYW Open Discussion
Elana Silber, MBA
Sharsheret
ACBCYW Committee Chair
12:15 – 12:30 p.m.
Public Comment
12:30 – 1:00 p.m.
Summary and Closing
Elana Silber, MBA
Sharsheret
ACBCYW Committee Chair